Beryl Drugs Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 837 shares,. Its Average Traded Price (ATP) is ₹23.33, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 50 @ ₹23.99.
Beryl Drugs has an upper circuit limit of ₹28.78 and a lower circuit limit of ₹19.20. The total value traded stands at ₹19527.21, and the delivery percentage for the day is 91.09%.
The stock is currently traded with a market lot size of 1. Beryl Drugs also offers a dividend yield of 0%.
Beryl Drugs Share Price Chart
Beryl Drugs Share Key Metrics
Volume
837.00
Market Cap
12.17 CR
LTQ@LTP
50@23.99
ATP
23.33
Var Margin
30.54 %
Circuit Range
19.2-28.78
Delivery %
91.09 %
Value
19527.21
ASM/GSM
No
Market Lot
1
Beryl Drugs Resistance and Support
Pivot 24.35
Resistance
First Resistance
25.18
Second Resistance
26.23
Third Resistance
27.06
Support
First Support
23.3
Second Support
22.47
Third Support
21.42
Beryl Drugs Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Beryl Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-09-02 | A.G.M. |
| 2026-08-11 | Quarterly Results |
| 2026-06-16 | Others |
| 2026-05-28 | Audited Results |
| 2026-04-01 | Notice of EGM & Others |
| 2026-02-09 | Quarterly Results |
| 2026-01-03 | Others |
| 2025-11-13 | Quarterly Results |
| 2025-09-02 | A.G.M. |
| 2025-08-07 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-08 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Beryl Drugs News
Beryl Drugs Ltd - 524606 - RECORD DATE FOR THE PURPOSE OF 33RD ANNUAL GENERAL MEETING
Beryl Drugs fixed September 22, 2026, as the record date. This date determines voting eligibility for shareholders for remote e-voting at the upcoming 33rd Annual General Meeting.
Sep 03 2026 00:00:03
Beryl Drugs Ltd - 524606 - Board Meeting Outcome for OUTCOME OF BOARD MEETING
Beryl Drugs board approved an increase in the limit of material related party transactions with Aminova Infusions Pvt. Ltd. This approval suggests potential growth in business dealings between the two entities and was part of a board meeting that also finalized the 33rd Annual General Meeting arrangements.
Sep 02 2026 17:11:22
Beryl Drugs Ltd - 524606 - Board Meeting Intimation for Approve Board Report And Other Matters Related To 33Rd Annual General Meeting Of The Company
Beryl Drugs board will convene on September 2, 2026, to consider a proposal to increase the limit for material related party transactions with Aminova Infusions Pvt. Ltd. The meeting will also address preparations for the 33rd Annual General Meeting.
Aug 27 2026 21:45:23
Beryl Drugs Management
| Name | Position |
|---|---|
| Sanjay Sethi | Managing Director |
| Sudhir Sethi | Chairman |
Beryl Drugs Similar Stocks
Bacil Pharma Ltd.
19.38
0.92 (4.98%)
Ishita Drugs & Industries Ltd.
73.75
-0.25 (0.34%)
Emmessar Biotech & Nutrition Ltd.
23.58
-0.91 (3.72%)
Sharma East India Hospitals & Medical Research Ltd
92.00
1.58 (1.75%)
Norris Medicines Ltd.
15.22
0.72 (4.97%)
Soni Medicare Ltd.
0.00
0.00 (0.00%)
Parmax Pharma Ltd.
133.75
0.00 (0.00%)
Colinz Laboratories Ltd.
72.50
0.00 (0.00%)
Beryl Drugs FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in BERLDRG
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC